SP-MHCI-1293-2

Dihydrolipoyllysine acetyltransferase - pyruvate dehydrogenase, GDLIAEVETDKATV

US$169.00

In stock

Description

About Dihydrolipoyllysine acetyltransferase - pyruvate dehydrogenase, GDLIAEVETDKATV

The Human Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial Peptide (IEDB: 125061) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial Peptide, H-GDLIAEVETDKATV-OH (Uniprot: P10515 aa: 122-135) from JPT is produced under strict quality control and quality management.

Dihydrolipoyllysine acetyltransferase - pyruvate dehydrogenase, GDLIAEVETDKATV - Specifications

  • Peptide sequence: H-GDLIAEVETDKATV-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Multiple sclerosis, Hepatocellular carcinoma, Melanoma, Breast cancer, Ovarian cancer, Leukemia, Lymphoma, Diabetes, Lung cancer, Leukemia, Adenocarcinoma,
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Dihydrolipoyllysine acetyltransferase - pyruvate dehydrogenase, GDLIAEVETDKATV

References:
Read References with JPT’s Antigen Peptides

Dihydrolipoyllysine acetyltransferase - pyruvate dehydrogenase, GDLIAEVETDKATV has been described in:
HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases., J Exp Med, 1995 (PMID: 7536796.0)
Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis., Gastroenterology, 2003 (PMID: 12806624.0)
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis., J Clin Invest, 1998 (PMID: 9819369.0)

Documentation

Documentation for Dihydrolipoyllysine acetyltransferase - pyruvate dehydrogenase, GDLIAEVETDKATV

Properties

Properties of Dihydrolipoyllysine acetyltransferase - pyruvate dehydrogenase, GDLIAEVETDKATV

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Adenocarcinoma, Breast cancer, Diabetes, Hepatocellular carcinoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple sclerosis, Ovarian cancer
Layout: Freeze-dried in glass vial
Organism: Human
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No

Further Information to Dihydrolipoyllysine acetyltransferase - pyruvate dehydrogenase, GDLIAEVETDKATV

Information Values
Sequence: H-GDLIAEVETDKATV-OH
Specifications: 14mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote